FDA ODE II Overhaul Continues: Rarick Returns, Sobel Moves Up

FDA is completing a change of the guard in the Office of Drug Evaluation II with the appointment of Reproductive & Urologic Drug Products Division Director Lisa Rarick, MD, as ODE II deputy director.